NECITUMUMAB y avances en el tratamiento de 1ª línea carcinoma de pulmón escamoso - page 11

Análisis por sub-grupos (EGFR IHC)

(EGFR>0, EGFR=0)

SEO Version

Warning.

You are currently viewing the SEO version of !text.
It has a number of design and functionality limitations.

We recommend viewing the Flash version or the basic HTML version of this publication.

1...,2,3,4,5,6,7,8,9,10 12,13,14,15,16,17,18,19,20,...21